In an interview with BioMedGPS, Medtronic’s Marshall Stanton, MD discussed the Company’s strategies for gaining back market share in spinal cord stimulation and ongoing efforts to find the sweet spot in treating chronic intractable pain.
3 min read
Finding the Sweet Spot: Medtronic’s Growth Strategies for Spinal Cord Stimulation
By Anne Staylor on 2/25/17 12:00 PM
2 min read
BioMedGPS Announces Expansion of SmartTRAK Business Intelligence to the Neuromodulation and Neurovascular Markets
By Anne Staylor on 1/25/17 5:46 PM
January 25, 2017 02:46 PM Eastern Standard Time
IRVINE, Calif.--(BUSINESS WIRE)--BioMedGPS, the leading provider of real-time business analytics and analysis of the orthopedic/spine, wound care and regenerative medicine markets, announces expanded coverage of SmartTRAK Business Intelligence to the Neuro Therapies market with the introduction of SmartTRAK Neuromodulation and SmartTRAK Neurovascularmodules.